India · Delayed Price · Currency is INR Vaishali Pharma Statistics
Total Valuation
Vaishali Pharma has a market cap or net worth of INR 931.50 million. The enterprise value is 1.11 billion.
| Market Cap | 931.50M |
| Enterprise Value | 1.11B |
Important Dates
The last earnings date was Saturday, May 30, 2026.
| Earnings Date | May 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaishali Pharma has 130.46 million shares outstanding. The number of shares has increased by 2.90% in one year.
| Current Share Class | 130.46M |
| Shares Outstanding | 130.46M |
| Shares Change (YoY) | +2.90% |
| Shares Change (QoQ) | -1.01% |
| Owned by Insiders (%) | 47.17% |
| Owned by Institutions (%) | n/a |
| Float | 67.45M |
Valuation Ratios
The trailing PE ratio is 22.31.
| PE Ratio | 22.31 |
| Forward PE | n/a |
| PS Ratio | 0.83 |
| PB Ratio | 1.35 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.56 |
| EV / Sales | 0.98 |
| EV / EBITDA | 14.31 |
| EV / EBIT | 14.78 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.34 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 2.49 |
| Debt / FCF | n/a |
| Interest Coverage | 3.74 |
Financial Efficiency
Return on equity (ROE) is 6.21% and return on invested capital (ROIC) is 6.58%.
| Return on Equity (ROE) | 6.21% |
| Return on Assets (ROA) | 3.94% |
| Return on Invested Capital (ROIC) | 6.58% |
| Return on Capital Employed (ROCE) | 9.79% |
| Weighted Average Cost of Capital (WACC) | 6.58% |
| Revenue Per Employee | 41.71M |
| Profits Per Employee | 1.54M |
| Employee Count | 27 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 23.17 |
Taxes
In the past 12 months, Vaishali Pharma has paid 13.55 million in taxes.
| Income Tax | 13.55M |
| Effective Tax Rate | 24.55% |
Stock Price Statistics
The stock price has decreased by -43.24% in the last 52 weeks. The beta is 0.38, so Vaishali Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -43.24% |
| 50-Day Moving Average | 7.12 |
| 200-Day Moving Average | 8.73 |
| Relative Strength Index (RSI) | 49.35 |
| Average Volume (20 Days) | 94,251 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vaishali Pharma had revenue of INR 1.13 billion and earned 41.65 million in profits. Earnings per share was 0.32.
| Revenue | 1.13B |
| Gross Profit | 174.85M |
| Operating Income | 73.49M |
| Pretax Income | 55.20M |
| Net Income | 41.65M |
| EBITDA | 75.94M |
| EBIT | 73.49M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 14.30 million in cash and 188.90 million in debt, with a net cash position of -174.60 million or -1.34 per share.
| Cash & Cash Equivalents | 14.30M |
| Total Debt | 188.90M |
| Net Cash | -174.60M |
| Net Cash Per Share | -1.34 |
| Equity (Book Value) | 691.15M |
| Book Value Per Share | 5.30 |
| Working Capital | 646.64M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.45M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 15.53%, with operating and profit margins of 6.53% and 3.70%.
| Gross Margin | 15.53% |
| Operating Margin | 6.53% |
| Pretax Margin | 4.90% |
| Profit Margin | 3.70% |
| EBITDA Margin | 6.74% |
| EBIT Margin | 6.53% |
| FCF Margin | n/a |
Dividends & Yields
Vaishali Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.90% |
| Shareholder Yield | -2.90% |
| Earnings Yield | 4.47% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 15, 2024. It was a forward split with a ratio of 10.
| Last Split Date | Oct 15, 2024 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |